CVE-2026-112047OneUptime 14.0.2 before 14.0.69 Incorrect Authorization in Kubernetes AI Actions
Updated under an hour ago ()
Does this affect you?
It affects oneuptime. Add what you run to find out whether that includes you.
No exploitation reported and no EPSS estimate yet.
Do this next
Free account, 1 product
OneUptime 14.0.2 before 14.0.69 contains an incorrect authorization vulnerability that allows authenticated project members to act on clusters outside their scope by exploiting project-wide permission checks. Attackers can call the AI access test, agent reset, kubectl plan approval and incident AI conversation features to learn agent RBAC permissions, disconnect agents, approve kubectl changes, or run commands on unauthorized resources.
- CVSS
- 5.4 MEDIUM (v3.1, CNA)CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:N
- Weakness (CWE)
- CWE-863
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- Not loaded for this CVE
- Assigned by
- VulnCheck
- NVD analysis
- Deferred
- Record last updated
- Oct 18, 2026
- First seen by InfoSec Signals
- Oct 18, 2026
Affected products
OneUptime oneuptime oneuptime:oneuptime (from the name) | from 14.0.2 before 14.0.69 | CNA record |
References
- https://github.com/OneUptime/oneuptime/security/advisories/GHSA-8fph-9j9f-xxgcvendor-advisory
- https://github.com/OneUptime/oneuptime/commit/264e1ba13149cbd4c80cb22f2177b405886b0452patch
- https://github.com/OneUptime/oneuptime/releases/tag/14.0.69release-notes
- https://github.com/OneUptime/oneuptime/blob/14.0.68/packages/Common/Server/API/KubernetesClusterAiAccessAPI.ts#L188-L207technical-description
- https://www.vulncheck.com/advisories/oneuptime-14.0.2-before-14.0.69-incorrect-authorization-in-kubernetes-ai-actionsthird-party-advisory
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.